Zoetis, Inc. (ZTS)
126.65
+1.01
(+0.80%)
USD |
NYSE |
Feb 13, 16:00
126.50
-0.15
(-0.12%)
After-Hours: 20:00
Zoetis Cash from Investing (Quarterly) : -160.00M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Elanco Animal Health, Inc. | -101.00M |
| Bristol Myers Squibb Co. | -1.458B |
| Pfizer Inc. | -- |
| Regeneron Pharmaceuticals, Inc. | 220.30M |
| Moderna, Inc. | 700.00M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 938.00M |
| Cash from Financing (Quarterly) | -134.00M |
| Free Cash Flow | 2.24B |
| Free Cash Flow Per Share (Quarterly) | 1.816 |
| Free Cash Flow to Equity (Quarterly) | 323.00M |
| Free Cash Flow to Firm (Quarterly) | 857.02M |
| Free Cash Flow Yield | 3.96% |